首页> 美国卫生研究院文献>Neuropsychiatric Disease and Treatment >Need for medication to complement catecholamines in smoking cessation of hardcore smokers
【2h】

Need for medication to complement catecholamines in smoking cessation of hardcore smokers

机译:铁杆吸烟者戒烟中需要补充儿茶酚胺的药物

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Many smokers find it difficult to stop smoking without assistance. The antidepressants bupropion and nortriptyline can aid smoking cessation. The main aim of this study was to understand the pathophysiology of smoking cessation better based on biological backgrounds. We investigated the following biological markers for any alterations during smoking cessation in the absence of pharmacotherapy: the dopamine metabolite homovanillic acid (HVA), the noradrenaline metabolite 3-methoxy-4-hydroxyphenylglycol (MHPG) and brain-derived neurotrophic factor (BDNF). Assessment and blood sampling were performed at a baseline (the start) time point and at a critical time point during smoking cessation. Seven of 30 smokers quit during a 16-week follow-up period; these smokers were defined as remission group from tobacco dependence. The remaining 23 smokers were categorized as hardcore smokers. The smoking group was compared with 23 non-smokers matched for age and gender. We compared blood levels of biological markers in each of the three groups. The hardcore smoker group showed significant decreases in HVA and MHPG levels between baseline and the critical time point (p=0.018 and p=0.033, respectively). However, the remission from tobacco dependence group exhibited no significant changes in any of the biomarkers examined. They had lower scores on the Minnesota nicotine withdrawal scale than the hardcore smoker group (p=0.002). The hardcore smoker group had higher MHPG and BDNF levels than the non-smoker group (p=0.002 and p<0.001, respectively). Hardcore smokers experience severe nicotine withdrawal symptoms. Nicotine withdrawal is associated with catecholamine deficiency. The resulting withdrawal symptoms make quitting difficult for hardcore smokers. These hardcore smokers may require medication to compensate for the catecholamine deficit. Non-nicotinic medications such as bupropion, nortriptyline, or varenicline may be required to bolster the catecholamine deficit in hardcore smokers.
机译:许多吸烟者发现没有帮助就很难戒烟。抗抑郁药安非他酮和去甲替林可帮助戒烟。这项研究的主要目的是根据生物学背景更好地了解戒烟的病理生理学。我们调查了以下在没有药物治疗的情况下戒烟期间任何改变的生物学标志物:多巴胺代谢物高香草酸(HVA),去甲肾上腺素代谢物3-甲氧基-4-羟苯基乙二醇(MHPG)和脑源性神经营养因子(BDNF)。在基线(开始)时间点和戒烟期间的关键时间点进行评估和血液采样。在16周的随访期内,每30名吸烟者中有7名戒烟。这些吸烟者被定义为因烟草依赖而缓解的人群。其余23名吸烟者被归类为“顽固吸烟者”。将吸烟组与23个年龄和性别相匹配的非吸烟者进行比较。我们比较了三组中每组的血液中生物标志物的水平。铁杆吸烟者组在基线和关键时间点之间的HVA和MHPG水平显着下降(分别为p = 0.018和p = 0.033)。但是,从烟草依赖组中获得的缓解在所检查的任何生物标志物中均未表现出显着变化。他们在明尼苏达州尼古丁戒断量表上的得分低于铁杆吸烟者组(p = 0.002)。顽固吸烟者组的MHPG和BDNF水平高于非吸烟者(分别为p = 0.002和p​​ <0.001)。顽固的吸烟者会出现严重的尼古丁戒断症状。尼古丁戒断与儿茶酚胺缺乏有关。由此产生的戒断症状使铁杆吸烟者很难戒烟。这些顽固的吸烟者可能需要药物来补偿儿茶酚胺不足。可能需要非烟碱类药物,例如安非他酮,去甲替林或伐尼克兰,以加强顽固性吸烟者的儿茶酚胺缺乏症。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号